Clinical Trial Update: Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma [NA]

View source ↗

Summary

This document reports a clinical trial update examining how apixaban affects thrombin generation in patients with de novo multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Multiple Myeloma, Total Knee Replacement | NA | Status: RECRUITING